• Explore /
  • Poster
  • / TmPSMA-02: A CD2 endodomain containing double armored PSMA CAR T with enhanced efficacy and lower immune toxicity.

TmPSMA-02: A CD2 endodomain containing double armored PSMA CAR T with enhanced efficacy and lower immune toxicity.

Abstract Poster

Authors

null

David Barrett

TMUNITY Therapeutics, Inc., Philadelphia, PA

David Barrett , Karen Chagin , Thomas J. Fountaine , Andrea Moore , Mignane Ka , Whitney Gladney , Bhavna Verma , Yanping Luo , Daniel Hui , Vijay Gopal Reddy Peddareddigari

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 158)

DOI

10.1200/JCO.2022.40.6_suppl.158

Abstract #

158

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Carlos A. Gomez-Roca

First Author: Jee Soo Park

First Author: Giulia Pasello

First Author: Meredith McKean